Clelia Asero
Messina, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Body composition assessment for risk stratification of hepatic steatosis in patients with type 2 diabetes and MASLD undergoing osteoporosis screening.
Journal: Frontiers in endocrinology
Published: June 06, 2026
From Cure to Complexity: Post-SVR Liver and Metabolic Trajectories in Diabetic Patients.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 09, 2025
Trabecular bone score enhances fracture risk stratification in patients with metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus.
Journal: Journal of endocrinological investigation
Published: December 01, 2025
Neurofilament light chain proteins are a sensitive biomarker of neuronal damage in cirrhotic patients with hepatic encephalopathy.
Journal: Frontiers in molecular biosciences
Published: November 11, 2025
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression.
Journal: International journal of molecular sciences
Published: July 17, 2025
High Prevalence of Severe Hepatic Fibrosis in Type 2 Diabetic Outpatients Screened for Non-Alcoholic Fatty Liver Disease.
Journal: Journal of clinical medicine
Published: March 08, 2023
Impact of Sex and Gender on Clinical Management of Patients with Advanced Chronic Liver Disease and Type 2 Diabetes.
Journal: Journal of personalized medicine
Published: December 28, 2022
Hypergammaglobulinemia before Starting DAA Therapy Is A Strong Predictor of Disease Progression in Cirrhotic Patients Even after HCV Clearance.
Journal: Journal of personalized medicine
Published: September 30, 2022
Showing 1-8 of 8
Last Updated: 09/26/2026